乌鸦传媒

Oncology/Hematology

<乌鸦传媒 class='mpt-top_cat_title_description'>News, opinions and meeting coverage in oncology/hematology.

<乌鸦传媒>A Patient's Journey: Celebrity Revelation Stirs the Pot

Ben Stiller says PSA testing saved his life. Did it really?

<乌鸦传媒>CML Patients Still Benefit from Transplant

Also at SOHO: Ponatinib proves mettle in pretreated CML

<乌鸦传媒>MedPAC Looks at Ways to Adjust Misvalued Services

Commission debates grouping CPT codes into families

<乌鸦传媒>Hypomethylating Agents Useful in Low-Risk MDS

Objective responses in a majority of patients

<乌鸦传媒>A Patient's Journey: Can High-Grade PIN Be 'Great News'?

Biopsy vacation ends, worry index jumps

<乌鸦传媒>ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

<乌鸦传媒>Is Keytruda Better than Opdivo?

Trial results begin to suggest an advantage

<乌鸦传媒>Fatal Illness Contracted From Bagpipes

Playing 'the pipes' can be deadly

<乌鸦传媒>Fraud Rounds: Grant Fakery Earns Practice Ban

Cancer researcher struck from U.K. medical register after fabricating data in grant applications

<乌鸦传媒>Make the Diagnosis: More Than A Rash

Case Findings: A 51-year-old woman visited her primary care doctor complaining of a rash, pruritus, myalgias, and muscle weakness that made normally easy tasks like standing from a seated position difficult. The rash was an erythematous blanching patch, spread across her back and shoulders like a shawl and across her chest in a V shape. She had also noticed that her fingernail folds were red and swollen. What is your diagnosis?

<乌鸦传媒>Make the Diagnosis: Leg Lesion Teaser

Case Findings: A 47-year-old woman undergoing chemotherapy for breast cancer noticed several red, flaccid bullae on her leg. She was also experiencing fever, cough, and shortness of breath, which developed quickly, so she went to the ED. What is your diagnosis?

<乌鸦传媒>Prostate Cancer: Informed Decisions or Information Overload?

To biopsy, or not to biopsy -- a Shakespearean dilemma

<乌鸦传媒>New Standard for Older Patients With Glioblastoma

Radiation plus temozolomide extends survival

<乌鸦传媒>Pembrolizumab Plus Lenalidomide Gets Response in MM

Combo shows signs of benefit in relapsed/refractory myeloma

<乌鸦传媒>Novel Agent Promising in Pretreated Myeloma

Phase II trial shows 18-month median survival with isatuximab

<乌鸦传媒>Plitidepsin Shows Activity in Multiple Myeloma

Early data favorable for sea squirt drug

<乌鸦传媒>Practice Changer: Tandem Transplant for Neuroblastoma

13% absolute increase in 3-year event-free survival

<乌鸦传媒>New Trial 'Justifies' FDA Nod for Ibrance

Phase III study had almost identical results as pivotal trial

<乌鸦传媒>Widely Used Breast Chemo Regimen Falls Short

Taxane-cyclophosphamide regimens fail against taxane-anthracycline combinations

<乌鸦传媒>Study: Minorities Less Likely to Get Ca Risk Management

Less genetic testing, bilateral mastectomy in black BRCA carriers

<乌鸦传媒>Novel App Seems to Extend Lung Cancer Survival

Web app offers early detection of relapse, complications between healthcare visits

<乌鸦传媒>Combo Boosts PFS in Tough-to-Treat Myeloma

Recurrent or relapsed disease susceptible to daratumumab-bortezomib-dexamethasone

<乌鸦传媒>Revlimid Maintenance Benefits Multiple Myeloma

Prolonged overall survival in patients post-autologous stem cell transplant

<乌鸦传媒>Longer Letrozole Equals Less BRCA Recurrence

Study suggests that 10 years is better than five

<乌鸦传媒>Antibody Shines in Advanced Gastric Cancer

IMAB362 leads to longer remission, better survival

<乌鸦传媒>Novel Agent Offers Hope in Small Cell Lung Cancer

Antibody-drug conjugate Rova-T looks good, but in very early trial

<乌鸦传媒>Gemcitabine-Capecitabine Tx: The New Standard in Pancreatic Ca?

Five-year survival reaches all-time high in post-surgical patients

<乌鸦传媒>Adjuvant Chemo a Winner in Rare Brain Cancer

Significant survival bump in nondeleted anaplastic glioma

<乌鸦传媒>Trastuzumab Biosimilar Shows Similar Effects

Near-copy of Herceptin may improve global access to treatment

<乌鸦传媒>Palliative Care Benefits Caregivers, Too

Better QoL, less depression among 'downstream' effects

<乌鸦传媒>Transplant Remains King for New Myeloma

Significant improvement in PFS versus systemic treatment

<乌鸦传媒>ASCO: Tumor 'Sidedness' Affects Survival

New analysis of colon cancer trial could aid treatment decisions

<乌鸦传媒>'Cautious Optimism' for HIFU in Prostate Cancer

Radical treatment avoided for 2 years in 90% of patients

<乌鸦传媒>No Evidence of TRT Link to Prostate Cancer

Observational studies back testosterone safety

<乌鸦传媒>Landmark Trial Not a Measure of PSA Value

High rate of 'contamination' in control arm of PLCO trial

<乌鸦传媒>Seeking Meaning in Ca Survival Risk Estimates

Most estimates from unselected adults not in the 'ballpark'

<乌鸦传媒>AUA: Striving to Reach All in Urology

Controversy, science, drama, and Mother's Day at annual meeting

<乌鸦传媒>Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

<乌鸦传媒>10 Questions: Ilona J. Frieden, MD

'The structure of the system itself is the biggest barrier'

<乌鸦传媒>When "Unremarkable" Is Not Clear Enough

Radiology reports need to be held to higher standards, argues Saurabh Jha, MD

鈥�

68

鈥�